Rare Disease Report

CHOP Constructs $50 Million Pediatric Genetics Research Program

SEPTEMBER 23, 2016
RDR Staff
The Children's Hospital of Philadelphia (CHOP) has created a $50 Million pediatric genetics research and patient care initiative that will take a multidisciplinary approach toward diagnostics, clinical management, consulting, therapeutics and research driven by the focus of genetics.
Through the collaboration, the hospital will expand genomic testing, using the latest sequencing and computing techniques to search a patient’s DNA code for variations that affect health or response to therapies.
The “Roberts Collaborative for Genetics and Individualized Medicine”  is also creating a genomic data repository, a family support and counseling center, and a program to train medical students and residents in personalized pediatric care.
The Roberts Collaborative for Genetics and Individualized Medicine at CHOP will be sourced by external funding along with a $25 million gift that will help integrate clinical departments, and divisions and centers for the care of pediatric patients

The core components of the Roberts Collaborative for Genetics and Individualized Medicine include:

  • Genetic Diagnostics – through the efforts of the Division of Genomic Diagnostics.
  • Clinical Support and Counseling – by the newly established Roberts Individualized Medical Genetics Center at CHOP's Buerger Center for Advanced Pediatric Care, located on the Raymond G. Perelman Campus.
  • Education – for patients, families and clinicians on genetic diagnostics.
  • Training – of residents and medical students about individualized pediatric care.
  • Informatics – developing innovative solutions to healthcare informatics needs through CHOP's Department of Biomedical and Health Informatics.
  • Therapeutics – identifying targeted therapeutic options based on an individual's genetic information.
  • Research and Development – the creation of a data repository that will help fuel discovery of rare and complex traits, transforming them into novel diagnostic and therapeutic solutions. Components include Core Laboratories, Drug Screening, Clinical and Research Consent Development and the Biorepository at CHOP. The Raymond G. Perelman Center for Cellular and Molecular Therapeutics (CCMT) will help to facilitate the rapid translation of pre-clinical discoveries into clinical application.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.